David, J. A., Rifkin, W. J., Rabbani, P. S., & Ceradini, D. J. The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus. Wiley.
Chicago Style (17th ed.) CitationDavid, Joshua A., William J. Rifkin, Piul S. Rabbani, and Daniel J. Ceradini. The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus. Wiley.
MLA (9th ed.) CitationDavid, Joshua A., et al. The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus. Wiley.
Warning: These citations may not always be 100% accurate.